Naohiro Watanabe
Nagoya, 4648681, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Five-year prognostic impact of pre-existing interstitial lung disease in non-small cell lung cancer patients treated with anti-PD-1 monotherapy: a retrospective analysis.
Journal: BMC cancer
Published: February 01, 2026
Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC.
Journal: Cancer science
Published: July 17, 2025
Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1-Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study.
Journal: Cancer research communications
Published: March 26, 2025
Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 10, 2024
Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report.
Journal: Case reports in oncology
Published: May 23, 2024
The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review.
Journal: Frontiers in oncology
Published: April 17, 2024
Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer.
Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 26, 2024
Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease.
Journal: Journal of thoracic disease
Published: January 07, 2024
Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis.
Journal: BMC cancer
Published: December 17, 2023
Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer.
Journal: The oncologist
Published: April 13, 2023
Emerging therapies for non-small cell lung cancer harboring EGFR exon 20 insertion mutations: narrative review.
Journal: Annals of translational medicine
Published: September 29, 2022
Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study.
Journal: The oncologist
Published: February 22, 2022
Last Updated: 09/26/2026